Share-based payments (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Disclosure of terms and conditions of share-based payment arrangement [abstract] |
|
| Schedule of weighted average inputs of fair value of options granted |
The weighted average inputs used in computing the fair value of options granted were as follows:
|
| Disclosure of detailed information about share based payment expense |
Share-based payment expense | | For the Year Ended March 31, | | | | | | | | | | | | Equity settled share-based payment expense (1) | | | | | | | | | | | | | Cash settled share-based payment expense (2) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | As of March 31,2026 and 2025, there was Rs.433 and Rs.430, respectively, of total unrecognized compensation cost related to unvested stock options. This cost is expected to be recognized over a weighted-average period of 1.72 years and 1.68 years, respectively. |
| | Certain of the Company’s employees are eligible to receive share based payment awards that are settled in cash. These awards vest only upon satisfaction of certain service conditions which range from 1 to 4 years. A category of these awards are also linked to the overall performance of the company. These awards entitle the employees to a cash payment on the vesting date. The amount of the cash payment is determined based on the share price of the Company at the time of vesting. As of March 31, 2026 and 2025, there was Rs.396 and Rs.366, respectively, of total unrecognized compensation cost related to unvested awards. This cost is expected to be recognized over a weighted-average period of 1.87 years and 1.57 years , respectively. This scheme does not involve dealing in or subscribing to or purchasing securities of the Company, directly or indirectly. |
|
| Disclosure And Details About 2018 Plan |
The DRL 2018 Plan provides for option grants having an exercise price equal to the fair market value of the underlying equity shares on the date of grant are as follows after giving effect of stock split in October 2024: | | | | | | | | | | Options reserved against equity shares | | | | | | | | | | | | | Options reserved against ADRs | | | | | | | | | | | | | | | | | | | | | | | | | |
The outstanding shares purchased from secondary market as of March 31,2026 and 2025, are 1,965,575 and 2,452,260 shares for an aggregate consideration of Rs.1,815 and Rs.2,264, respectively.
|
| DRL 2018 Plan [member] |
|
| Disclosure of terms and conditions of share-based payment arrangement [abstract] |
|
| Disclosure Of Number Of Share Options, Weighted Average Exercise Price, Range Of Exercise Prices And Weighted Average Remaining Contractual Life |
Stock option activity under the DRL 2018 Plan during the years ended March 31, 2026 and 2025 was as follows: | | For the Year Ended March 31, 2026 | | Fair Market Value Options | | | | | | | | | | | | | Outstanding at the beginning of the year | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Expired/forfeited during the year | | | | | | | | | | | | | | | | | Exercised during the year | | | | | | | | | | | | | | | | | Outstanding at the end of the year | | | | | | | | | | | | | | | | | Exercisable at the end of the year | | | | | | | | | | | | | | | | |
|
|
|
For the Year Ended March 31, 2025
|
|
Fair Market Value Options
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the beginning of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired/forfeited during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DRL 2002 Plan [Member] |
|
| Disclosure of terms and conditions of share-based payment arrangement [abstract] |
|
| Disclosure of Number of Options Reserved |
After the stock split effected in the form of a stock dividend issued by the Company in August 2006 and October 2024, the DRL 2002 Plan provides for stock option grants in the above two categories as follows: | | | | | | | | | | Options reserved under original Plan | | | | | | | | | | | | | Options exercised prior to stock dividend date (A) | | | | | | | | | | | | | Balance of shares that can be allotted on exercise of options (B) | | | | | | | | | | | | | Options arising from stock dividend (C) | | | | | | | | | | | | | Options reserved after stock dividend (A+B+C) | | | | | | | | | | | | |
|
| Disclosure Of Number Of Share Options, Weighted Average Exercise Price, Range Of Exercise Prices And Weighted Average Remaining Contractual Life |
Category A — Fair Market Value Options: There was no stock activity under this category during the years ended March 31, 2026 and 2025, and there were no stock options outstanding under this category as of March 31, 2026 and 2025. Category B — Par Value Options: Stock options activity under this category during the years ended March 31, 2026 and 2025 was as set forth in the below table after giving effect to the stock split in October 2024. | | For the Year Ended March 31, 2026 | | Category B — Par Value Options | | | | | | | | | | | | | Outstanding at the beginning of the year | | | | | | | | | | | | | | | | | Expired/forfeited during the year | | | | | | | | | | | | | | | | | Exercised during the year | | | | | | | | | | | | | | | | | Outstanding at the end of the year | | | | | | | | | | | | | | | | | Exercisable at the end of the year | | | | | | | | | | | | | | | | |
| | For the Year Ended March 31, 2025 | | Category B — Par Value Options | | | | | | | | | | | | | Outstanding at the beginning of the year | | | | | | | | | | | | | | | | | Expired/forfeited during the year | | | | | | | | | | | | | | | | | Exercised during the year | | | | | | | | | | | | | | | | | Outstanding at the end of the year | | | | | | | | | | | | | | | | | Exercisable at the end of the year | | | | | | | | | | | | | | | | |
|
| DRL 2007 Plans [Member] |
|
| Disclosure of terms and conditions of share-based payment arrangement [abstract] |
|
| Disclosure Of Number Of Share Options, Weighted Average Exercise Price, Range Of Exercise Prices And Weighted Average Remaining Contractual Life |
The weighted average grant date fair value of options granted during the years ended March 31, 2026 and 2025 was Rs.388 and Rs.455 per option, respectively. The weighted average share prices on the date of allotment of options during the years ended March 31, 2026 and 2025 was Rs.1,306 and Rs.1,383 per share, respectively.
|
|
|
For the Year Ended March 31, 2026
|
|
Category B — Par Value Options
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the beginning of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired/forfeited during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | For the Year Ended March 31, 2025 | | Category B — Par Value Options | | | | | | | | | | | | | Outstanding at the beginning of the year | | | | | | | | | | | | | | | | | Expired/forfeited during the year | | | | | | | | | | | | | | | | | Exercised during the year | | | | | | | | | | | | | | | | | Outstanding at the end of the year | | | | | | | | | | | | | | | | | Exercisable at the end of the year | | | | | | | | | | | | | | | | |
|
| DRL 2007 Plans [Member] | Category A [Member] |
|
| Disclosure of terms and conditions of share-based payment arrangement [abstract] |
|
| Disclosure Of Number Of Share Options, Weighted Average Exercise Price, Range Of Exercise Prices And Weighted Average Remaining Contractual Life |
Stock options activity under the DRL 2007 Plan for the above two categories of options during the years ended March 31, 2026 and 2025 was as follows after giving effect to the stock split in October 2024:
|
|
|
For the Year Ended March 31, 2026
|
|
Category A — Fair Market Value Options
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the beginning of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired/forfeited during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended March 31, 2025
|
|
Category A — Fair Market Value Options
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the beginning of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired/forfeited during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at the end of the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|